the clinical significance in humans remains under investigation and is not yet established for retatrutide specifically [24] [25] Other class-associated cautions: Based on the broader GLP-1/GIP receptor agonist class, potential effects on gallbladder function and delayed gastric emptying are relevant considerations, though evidence specific to retatrutide is still emerging It is important to note that this evidence derives from early-phase trials conducted under controlled conditions with medical supervision
Some will be mild but uncomfortable, such as cramping, and others will be more severe, such as shortness of breath
Appetite suppression reduces your total food intake, which often means protein intake drops proportionally
SURMOUNT and STEP clinical trial data on weight plateau management
If patients experience severe gastrointestinal symptoms or dehydration, stopping GLP-1 therapy temporarily is advisable
After having had several disheartening experiences with past doctors, Gabby was encouraged by the support she received from her LifeMD care team
